title: Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
abstract: OBJECTIVE
  Infertility is one of the most common causes of women refer to gynecology clinics. Galactorrhea is defined as one of the causes of infertility caused by luteal phase defect and anovulatory cycles. The study aim was to investigate the effect of bromocriptine on pregnancy rate in infertile women with galactorrhea with or without high prolactin level.
  
  
  METHODS
  In a prospective study, consecutive women with infertility and galactorrhea who referred to Afzalipour Hospital and a private clinic during 5 years from May 2001 to May 2006 were included. The study was conducted on 205 infertile women (18-39 years) with galactorrhea. They were treated with 2.5 mg bromocriptine BID for up to 6 months.
  
  
  RESULTS
  The mean duration of sterility was 43.1 +/- 37.1 months (range, 12-16). 76.1% of patients showed positive signs for pregnancy. The pregnancy rate was 81.7% in the patients with high prolactin level (>20 ng/dl) and 74.3% in the patients with normal prolactin level (P = 0.26). There was a significant difference between mean duration of treatment with bromocriptine in women with and without pregnancy, 103.71 and 193.03 days, respectively (P < 0.001).
  
  
  CONCLUSIONS
  Considering the efficacy of bromocriptine in the treatment of infertile women with galactorrhea, we suggest treatment with bromocriptine in these patients regardless of serum prolactin level.
authors.affiliation: Department of Obstetrics & Gynecology, Kerman University of Medical Sciences and Health Services, Kerman, Iran. n_eftekhari2002@yahoo.com
authors.forename: Nahid
authors.initials: N
authors.lastname: Eftekhari
authors.forename: Sakineh
authors.initials: S
authors.lastname: Mohammadalizadeh
mesh_terms: D000293:Adolescent; D000328:Adult; D001971:Bromocriptine / Q000008:administration & dosage*; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006727:Hormone Antagonists / Q000008:administration & dosage*; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D007247:Infertility, Female / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008598:Menstruation; D011247:Pregnancy; D011256:Pregnancy Outcome; D018873:Pregnancy Rate; D011388:Prolactin / Q000097:blood; D011446:Prospective Studies; D055815:Young Adult
chemical_list: D006727:Hormone Antagonists; D001971:Bromocriptine; D011388:Prolactin